News

Find News

Filter articles

Showing 81 to 90 of 2876 results

Fasken hires Belmore Neidrauer partner

Canada24-01-2020Sarah Morgan

Jason Markwell, a former partner at Belmore Neidrauer, has joined Fasken’s IP group in its Toronto office.

CJEU upholds EMA’s right to publish drug firms’ clinical trial data

EU24-01-2020Edward Pearcey

The Court of Justice of the European Union has rejected two appeals that would have restricted the European Medicines Agency’s right to publish a pharmaceutical company’s clinical trial data, as it relates to their applications to market their products within the EU.

Ascenda claims fired COO tried to swap IP for $39m

23-01-2020Edward Pearcey

Molecular testing company Ascenda BioSciences is suing a former chief operations officer, claiming he attempted to “extort” the return of sensitive company information before taking up employment with a direct competitor.

Washington State Uni sues apple growers over ‘stolen’ variety

US23-01-2020Rory O'Neill

Washington State University is suing two apple producers who it says have infringed its patent through the unlicensed cultivation and sale of a proprietary apple variety.

GSK’s Seroxat pay-for-delay deals may restrict competition: AG

EU23-01-2020Sarah Morgan

GlaxoSmithKline may have restricted competition by making a deal with generic drugmakers to delay the launch of copies of an antidepressant, according to an adviser to the Court of Justice of the European Union.

Broad Institute presses for CRISPR settlement after EPO revocation

EU23-01-2020Rory O'Neill

A competitor of the Broad Institute has said that a European Patent Office ruling last week has weakened the CRISPR/Cas9 patent owner’s negotiating hand in any future settlement between the parties.

Latham & Watkins boosts team with life sciences litigator

US22-01-2020Sarah Morgan

A life sciences litigator from Williams & Connolly has joined Latham & Watkins’ Washington, DC office.

Big pharma is the ‘winner’ from US-China deal, say lawyers

China, US21-01-2020Rory O'Neill

Phase one of the US-China trade deal agreed last week is a major win for pharmaceutical companies, lawyers have told LSIPR.

USPTO denies Edwards' MitraClip patent challenge

US21-01-2020Edward Pearcey

The US Patent and Trademark Office has denied an inter partes review petition from Edwards Lifesciences, which argued that certain claims relating to Abbott’s MitraClip mitral valve repair device are unpatentable.

Illumina escapes genetics trade secrets claims

US17-01-2020Rory O'Neill

A US judge has thrown out a lawsuit accusing US biotechnology companies Illumina and Affymetrix of a “complex, multi-decade concerted effort” to conceal the theft of trade secrets in the 1990s.

Showing 81 to 90 of 2876 results

LSIPR